BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: White JM, Escorcia FE, Viola NT. Perspectives on metals-based radioimmunotherapy (RIT): moving forward. Theranostics 2021;11:6293-314. [PMID: 33995659 DOI: 10.7150/thno.57177] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Fan W, Zhang W, Allen S, Alshehri S, Muilenburg KM, Zheng C, Garrison JC. Examination of Charge Modifications of an Endolysosomal Trapping Inhibitor in an Antagonistic NTSR1-Targeted Construct for Colon Cancer. Bioconjug Chem 2022;33:1363-76. [PMID: 35793523 DOI: 10.1021/acs.bioconjchem.2c00214] [Reference Citation Analysis]
2 Rondon A, Rouanet J, Degoul F. Radioimmunotherapy in Oncology: Overview of the Last Decade Clinical Trials. Cancers (Basel) 2021;13:5570. [PMID: 34771732 DOI: 10.3390/cancers13215570] [Reference Citation Analysis]
3 Mccollum S, Kalivas A, Kirkham M, Kunz K, Okojie J, Pavek A, Barrott J. Oncostatin M Receptor as a Therapeutic Target for Radioimmune Therapy in Synovial Sarcoma. Pharmaceuticals 2022;15:650. [DOI: 10.3390/ph15060650] [Reference Citation Analysis]
4 Qin Y, Shen M, Liu X, Gu J, Zhu M, Yi X. Photo-Driven Delivery of 125I-Labeled Nanomicelles for Nucleus-Targeted Internal Conversion Electron-Based Cancer Therapy. ACS Appl Mater Interfaces 2021;13:49671-81. [PMID: 34652897 DOI: 10.1021/acsami.1c13249] [Reference Citation Analysis]
5 Ma H, Li F, Shen G, Pan L, Liu W, Liang R, Lan T, Yang Y, Yang J, Liao J, Liu N. In vitro and in vivo evaluation of 211At-labeled fibroblast activation protein inhibitor for glioma treatment. Bioorg Med Chem 2022;55:116600. [PMID: 34999526 DOI: 10.1016/j.bmc.2021.116600] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Imura R, Ozeki AN, Shida N, Kobayashi M, Ida H, Wada Y, Akimitsu N, Kumakura Y. Radiolabeling of PSMA-617 with 89Zr: A novel use of DMSO to improve radiochemical yield and preliminary small-animal PET results. Nucl Med Biol 2021;106-107:21-8. [PMID: 34998216 DOI: 10.1016/j.nucmedbio.2021.12.003] [Reference Citation Analysis]
7 Parrilha GL, dos Santos RG, Beraldo H. Applications of radiocomplexes with thiosemicarbazones and bis(thiosemicarbazones) in diagnostic and therapeutic nuclear medicine. Coordination Chemistry Reviews 2022;458:214418. [DOI: 10.1016/j.ccr.2022.214418] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]